Status:
ENROLLING_BY_INVITATION
Comparison Between Intravenous Hydrocortisone and Ondansetron in Prevention of Post Spinal Anesthesia Hypotension
Lead Sponsor:
Nada kamel Elgamal
Conditions:
Post Spinal Anaesthesia Hypotension
Eligibility:
All Genders
21+ years
Phase:
NA
Brief Summary
The purpose of this study is to assess and contrast the effectiveness of intravenous ondansetron and intravenous hydrocortisone in avoiding spinal anesthesia-induced hypotension.
Detailed Description
According to the medication investigated in this study, patients will be divided into three equal groups (40 each). Patients will receive one of the following 15 minutes before spinal anesthesia: 1. ...
Eligibility Criteria
Inclusion
- ASA I and II (physical status according to American Society of Anesthesiologists).
- Patients aged 21 years or more.
- Either sex.
- Abdominal and lower limb operations.
Exclusion
- Patient refusal.
- hemodynamic instability
- Hematological diseases, bleeding or coagulation abnormality.
- Local skin infection and sepsis at site of spinal anesthesia
- neuromuscular diseases (as myopathies, myasthenia gravies…)
- Preexisting neurological deficit or psychiatric diseases.
- Known intolerance to the study drugs.
- patients already receiving any of the study drugs.
- diabetic patient.
Key Trial Info
Start Date :
March 1 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
May 1 2025
Estimated Enrollment :
120 Patients enrolled
Trial Details
Trial ID
NCT06930456
Start Date
March 1 2024
End Date
May 1 2025
Last Update
April 16 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Port Said Hospital
Port Said, Port Said Governorate, Egypt